ALZCHEM GROUP AG (ACT.DE) Fundamental Analysis & Valuation

FRA:ACT • DE000A2YNT30

164.4 EUR
+1 (+0.61%)
Last: Mar 13, 2026, 10:54 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This ACT.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

7

Overall ACT gets a fundamental rating of 7 out of 10. We evaluated ACT against 67 industry peers in the Chemicals industry. ACT gets an excellent profitability rating and is at the same time showing great financial health properties. ACT is valued quite expensively, but it does show have an excellent growth rating. These ratings could make ACT a good candidate for growth and quality investing.


Dividend Valuation Growth Profitability Health

9

1. ACT.DE Profitability Analysis

1.1 Basic Checks

  • ACT had positive earnings in the past year.
  • ACT had a positive operating cash flow in the past year.
  • Each year in the past 5 years ACT has been profitable.
  • ACT had a positive operating cash flow in 4 of the past 5 years.
ACT.DE Yearly Net Income VS EBIT VS OCF VS FCFACT.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

1.2 Ratios

  • The Return On Assets of ACT (10.27%) is better than 94.03% of its industry peers.
  • ACT has a better Return On Equity (24.76%) than 97.01% of its industry peers.
  • ACT's Return On Invested Capital of 13.72% is amongst the best of the industry. ACT outperforms 94.03% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ACT is significantly above the industry average of 6.88%.
  • The last Return On Invested Capital (13.72%) for ACT is above the 3 year average (13.60%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 10.27%
ROE 24.76%
ROIC 13.72%
ROA(3y)9.87%
ROA(5y)8.8%
ROE(3y)24.16%
ROE(5y)24.97%
ROIC(3y)13.6%
ROIC(5y)11.74%
ACT.DE Yearly ROA, ROE, ROICACT.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • ACT has a Profit Margin of 11.29%. This is amongst the best in the industry. ACT outperforms 86.57% of its industry peers.
  • In the last couple of years the Profit Margin of ACT has grown nicely.
  • ACT has a better Operating Margin (16.87%) than 89.55% of its industry peers.
  • In the last couple of years the Operating Margin of ACT has grown nicely.
  • ACT's Gross Margin of 67.97% is amongst the best of the industry. ACT outperforms 97.01% of its industry peers.
  • ACT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 16.87%
PM (TTM) 11.29%
GM 67.97%
OM growth 3Y35.88%
OM growth 5Y14.09%
PM growth 3Y26.76%
PM growth 5Y16.8%
GM growth 3Y11.38%
GM growth 5Y1.65%
ACT.DE Yearly Profit, Operating, Gross MarginsACT.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. ACT.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ACT is creating value.
  • Compared to 1 year ago, ACT has less shares outstanding
  • ACT has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ACT has been reduced compared to a year ago.
ACT.DE Yearly Shares OutstandingACT.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
ACT.DE Yearly Total Debt VS Total AssetsACT.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • An Altman-Z score of 4.85 indicates that ACT is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 4.85, ACT belongs to the top of the industry, outperforming 92.54% of the companies in the same industry.
  • ACT has a debt to FCF ratio of 1.13. This is a very positive value and a sign of high solvency as it would only need 1.13 years to pay back of all of its debts.
  • ACT's Debt to FCF ratio of 1.13 is amongst the best of the industry. ACT outperforms 92.54% of its industry peers.
  • A Debt/Equity ratio of 0.14 indicates that ACT is not too dependend on debt financing.
  • ACT has a Debt to Equity ratio of 0.14. This is in the better half of the industry: ACT outperforms 74.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 1.13
Altman-Z 4.85
ROIC/WACC1.88
WACC7.31%
ACT.DE Yearly LT Debt VS Equity VS FCFACT.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M 250M

2.3 Liquidity

  • ACT has a Current Ratio of 2.49. This indicates that ACT is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.49, ACT is in the better half of the industry, outperforming 79.10% of the companies in the same industry.
  • ACT has a Quick Ratio of 1.52. This is a normal value and indicates that ACT is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.52, ACT is in the better half of the industry, outperforming 71.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.49
Quick Ratio 1.52
ACT.DE Yearly Current Assets VS Current LiabilitesACT.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. ACT.DE Growth Analysis

3.1 Past

  • ACT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.57%, which is quite good.
  • ACT shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 26.48% yearly.
  • ACT shows a small growth in Revenue. In the last year, the Revenue has grown by 1.42%.
  • The Revenue has been growing by 8.19% on average over the past years. This is quite good.
EPS 1Y (TTM)18.57%
EPS 3Y28.42%
EPS 5Y26.48%
EPS Q2Q%13.74%
Revenue 1Y (TTM)1.42%
Revenue growth 3Y1.21%
Revenue growth 5Y8.19%
Sales Q2Q%-1.26%

3.2 Future

  • The Earnings Per Share is expected to grow by 26.32% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, ACT will show a quite strong growth in Revenue. The Revenue will grow by 11.01% on average per year.
EPS Next Y5.53%
EPS Next 2Y15.99%
EPS Next 3Y26.32%
EPS Next 5YN/A
Revenue Next Year7.47%
Revenue Next 2Y12.07%
Revenue Next 3Y12.68%
Revenue Next 5Y11.01%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ACT.DE Yearly Revenue VS EstimatesACT.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
ACT.DE Yearly EPS VS EstimatesACT.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

3

4. ACT.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 26.10 indicates a quite expensive valuation of ACT.
  • ACT's Price/Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 25.71, ACT is valued at the same level.
  • With a Price/Forward Earnings ratio of 25.34, ACT can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ACT is on the same level as its industry peers.
  • When comparing the Price/Forward Earnings ratio of ACT to the average of the S&P500 Index (23.82), we can say ACT is valued inline with the index average.
Industry RankSector Rank
PE 26.1
Fwd PE 25.34
ACT.DE Price Earnings VS Forward Price EarningsACT.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • ACT's Enterprise Value to EBITDA ratio is in line with the industry average.
  • ACT's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 42.67
EV/EBITDA 13.47
ACT.DE Per share dataACT.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ACT does not grow enough to justify the current Price/Earnings ratio.
  • ACT has an outstanding profitability rating, which may justify a higher PE ratio.
  • ACT's earnings are expected to grow with 26.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)4.72
PEG (5Y)0.99
EPS Next 2Y15.99%
EPS Next 3Y26.32%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. ACT.DE Dividend Analysis

5.1 Amount

  • ACT has a Yearly Dividend Yield of 1.37%.
  • ACT's Dividend Yield is comparable with the industry average which is at 2.29.
  • ACT's Dividend Yield is slightly below the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.37%

5.2 History

  • The dividend of ACT is nicely growing with an annual growth rate of 19.13%!
Dividend Growth(5Y)19.13%
Div Incr Years5
Div Non Decr Years5
ACT.DE Yearly Dividends per shareACT.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • ACT pays out 28.66% of its income as dividend. This is a sustainable payout ratio.
  • ACT's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP28.66%
EPS Next 2Y15.99%
EPS Next 3Y26.32%
ACT.DE Yearly Income VS Free CF VS DividendACT.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M
ACT.DE Dividend Payout.ACT.DE Dividend Payout, showing the Payout Ratio.ACT.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ACT.DE Fundamentals: All Metrics, Ratios and Statistics

ALZCHEM GROUP AG

FRA:ACT (3/13/2026, 10:54:20 AM)

164.4

+1 (+0.61%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-27
Earnings (Next)04-30
Inst Owners41.61%
Inst Owner ChangeN/A
Ins Owners28%
Ins Owner ChangeN/A
Market Cap1.67B
Revenue(TTM)562.12M
Net Income(TTM)63.46M
Analysts87.27
Price Target180.48 (9.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.37%
Yearly Dividend1.79
Dividend Growth(5Y)19.13%
DP28.66%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)13.82%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.27%
EPS NY rev (3m)-7.02%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.43%
Revenue NY rev (3m)-1.96%
Valuation
Industry RankSector Rank
PE 26.1
Fwd PE 25.34
P/S 2.98
P/FCF 42.67
P/OCF 12.21
P/B 6.53
P/tB 6.62
EV/EBITDA 13.47
EPS(TTM)6.3
EY3.83%
EPS(NY)6.49
Fwd EY3.95%
FCF(TTM)3.85
FCFY2.34%
OCF(TTM)13.46
OCFY8.19%
SpS55.22
BVpS25.18
TBVpS24.83
PEG (NY)4.72
PEG (5Y)0.99
Graham Number59.74
Profitability
Industry RankSector Rank
ROA 10.27%
ROE 24.76%
ROCE 19.01%
ROIC 13.72%
ROICexc 16.03%
ROICexgc 16.16%
OM 16.87%
PM (TTM) 11.29%
GM 67.97%
FCFM 6.98%
ROA(3y)9.87%
ROA(5y)8.8%
ROE(3y)24.16%
ROE(5y)24.97%
ROIC(3y)13.6%
ROIC(5y)11.74%
ROICexc(3y)15.49%
ROICexc(5y)13.01%
ROICexgc(3y)15.65%
ROICexgc(5y)13.15%
ROCE(3y)18.84%
ROCE(5y)16.26%
ROICexgc growth 3Y18.84%
ROICexgc growth 5Y13.25%
ROICexc growth 3Y18.94%
ROICexc growth 5Y13.21%
OM growth 3Y35.88%
OM growth 5Y14.09%
PM growth 3Y26.76%
PM growth 5Y16.8%
GM growth 3Y11.38%
GM growth 5Y1.65%
F-Score7
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 1.13
Debt/EBITDA 0.3
Cap/Depr 366.97%
Cap/Sales 17.4%
Interest Coverage 54.63
Cash Conversion 112.78%
Profit Quality 61.81%
Current Ratio 2.49
Quick Ratio 1.52
Altman-Z 4.85
F-Score7
WACC7.31%
ROIC/WACC1.88
Cap/Depr(3y)203.37%
Cap/Depr(5y)168.11%
Cap/Sales(3y)9.66%
Cap/Sales(5y)8.22%
Profit Quality(3y)109.03%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.57%
EPS 3Y28.42%
EPS 5Y26.48%
EPS Q2Q%13.74%
EPS Next Y5.53%
EPS Next 2Y15.99%
EPS Next 3Y26.32%
EPS Next 5YN/A
Revenue 1Y (TTM)1.42%
Revenue growth 3Y1.21%
Revenue growth 5Y8.19%
Sales Q2Q%-1.26%
Revenue Next Year7.47%
Revenue Next 2Y12.07%
Revenue Next 3Y12.68%
Revenue Next 5Y11.01%
EBIT growth 1Y20.86%
EBIT growth 3Y37.52%
EBIT growth 5Y23.43%
EBIT Next Year45.22%
EBIT Next 3Y32.94%
EBIT Next 5Y22.28%
FCF growth 1Y-36.78%
FCF growth 3YN/A
FCF growth 5Y14.56%
OCF growth 1Y30.31%
OCF growth 3YN/A
OCF growth 5Y22.98%

ALZCHEM GROUP AG / ACT.DE FAQ

Can you provide the ChartMill fundamental rating for ALZCHEM GROUP AG?

ChartMill assigns a fundamental rating of 7 / 10 to ACT.DE.


What is the valuation status for ACT stock?

ChartMill assigns a valuation rating of 3 / 10 to ALZCHEM GROUP AG (ACT.DE). This can be considered as Overvalued.


Can you provide the profitability details for ALZCHEM GROUP AG?

ALZCHEM GROUP AG (ACT.DE) has a profitability rating of 9 / 10.


Can you provide the financial health for ACT stock?

The financial health rating of ALZCHEM GROUP AG (ACT.DE) is 9 / 10.


What is the earnings growth outlook for ALZCHEM GROUP AG?

The Earnings per Share (EPS) of ALZCHEM GROUP AG (ACT.DE) is expected to grow by 5.53% in the next year.